Archives

by in
Entry Author Date Location
Agios and Celgene: Anatomy of an Ultra-Valuable Biotech Marriage 10/11/11 Boston
Xconomist of the Week: Pfizer’s Barbara Dalton to Speak at Our NY Life Sciences 2031 Forum 09/29/11 New York
RXi Splits Into Two Public Companies After Adding Cancer Vaccine to Pipeline 09/26/11 Boston
Ariad Brings Third Cancer Drug Into Human Trials 09/22/11 Boston
J&J Honors Genentech Scientist, Holds Meeting on Future of Anti-Angiogenesis Drugs 09/15/11 New York
Aura Biosciences Raises $4.5M to Advance Nano-Drug Weapon Against Cancer 09/08/11 Boston
Lead Syndax Drug Shows Survival Benefits in Breast Cancer Trial 09/06/11 Boston
Delcath Takes FDA Hassle in Stride, Prepares to Sell New Chemo Device Overseas 08/17/11 New York
NYC’s Coronado Biosciences Plans Two Drug Trials, Wall Street Debut, and Boston Move 07/21/11 Boston
Veterans of J&J, Pfizer, and Medimmune Seek to Transform Arno into Oncology Powerhouse 07/19/11 New York
Amag Eyes Rebound, Idera Surges On Despite Merck KGaA Drop, Verastem Snags $32M, & More Boston-Area Life Sciences News 07/15/11 Boston
Sanofi Collaboration Drives Regeneron’s Transformation From R&D House to Commercial Player 07/13/11 New York
PTC Teams With AstraZeneca 06/29/11 New York
Curis and Genentech Unleash the Hedgehog to Fight a Deadly Skin Cancer 06/28/11 Boston
Constellation Pharma Raises More Money and Further Defines Pipeline 06/17/11 Boston
Stemline Makes Headway Against Cancer Stem Cells And Proves Value of Virtual Model 06/08/11 New York
New York Area Companies Head to ASCO With High Hopes For Future Cancer Blockbusters 06/01/11 New York
Cyclacel Looks to ASCO as Showcase for Potent Cancer-Fighting Cocktail 05/31/11 New York
Aveo Forms $15 Million Cancer Deal With J&J Unit 05/31/11 Boston
Pfizer Lung Cancer Drug to Get Priority Review 05/17/11 New York
FDA Panel OKs Vertex Drug, Dyax Works With FivePrime, Genzyme Amends Anika Lawsuit, & More Boston-Area Life Sciences News 04/29/11 Boston
New Oncology R&D House H3 Biomedicine Launches in Cambridge, With Eisai Support 01/28/11 Boston
Molecular Insight Announces Ch. 11, Restructuring 12/10/10 Boston
Anchor Therapeutics Hooks Deal Worth Up to $480M with J&J 09/09/10 Boston
Mercator Therapeutics Embarks on Journey to Develop Targeted Cancer Drugs 09/01/10 Boston
Aileron Inks Deal with Roche, Worth Up to $1.1B, to Develop Stapled Peptide Drugs 08/24/10 Boston
Conatus Gets Pfizer Subsidiary 08/02/10 San Diego
How Microsoft (and Startups) Can Make Money in Health IT, Personalized Medicine Is a “Crock,” and Other Highlights from the Xconomy Forum 05/14/10 Seattle
Epizyme Entices Broad Institute Player, Robert Gould, to Take Over as CEO 03/24/10 Boston
ASCO Sneak Peek: ImmunoGen, Biogen Idec, Infinity Show Glimpses of Cancer Drug Data 05/15/09 Boston
Page 2 of 3 « previous page · next page »